Today on Business as Usual, we are welcoming one of Pittsburgh's true technology/life sciences pioneers to the show -- Pete DeComo, CEO and Chairman of ALung Technologies. With 25-plus years of life sciences start up experience, Pete founded and shepherded Renal Solutions to a $200 million acquisition by Fresenius Medical Care before leading up ALung. Today Pete will discuss how ALung Technologies has become a leading developer of advanced medical devices for treating respiratory failure. ALung’s Hemolung Respiratory Assist System (RAS) is a dialysis-like alternative or supplement to mechanical ventilation originally developed at the University of Pittsburgh which removes carbon dioxide directly from the blood in patients with acute respiratory failure. Come hear more about ALung's remarkable journey and Pete's dedication to scaling this tremendous business!
